BR112022020003A2 - Matriz de tecido adiposo com tropoelastina - Google Patents
Matriz de tecido adiposo com tropoelastinaInfo
- Publication number
- BR112022020003A2 BR112022020003A2 BR112022020003A BR112022020003A BR112022020003A2 BR 112022020003 A2 BR112022020003 A2 BR 112022020003A2 BR 112022020003 A BR112022020003 A BR 112022020003A BR 112022020003 A BR112022020003 A BR 112022020003A BR 112022020003 A2 BR112022020003 A2 BR 112022020003A2
- Authority
- BR
- Brazil
- Prior art keywords
- tropoelastin
- products
- tissue
- adipose tissue
- tissue matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/12—Mammary prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C67/00—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
- B29C67/20—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 for porous or cellular articles, e.g. of foam plastics, coarse-pored
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/04—Materials or treatment for tissue regeneration for mammary reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/04—Condition, form or state of moulded material or of the material to be shaped cellular or porous
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2995/00—Properties of moulding materials, reinforcements, fillers, preformed parts or moulds
- B29K2995/0037—Other properties
- B29K2995/0056—Biocompatible, e.g. biopolymers or bioelastomers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Mechanical Engineering (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063004794P | 2020-04-03 | 2020-04-03 | |
| PCT/US2021/025523 WO2021202965A1 (en) | 2020-04-03 | 2021-04-02 | Adipose tissue matrix with tropoelastin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022020003A2 true BR112022020003A2 (pt) | 2022-12-13 |
Family
ID=75640015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022020003A BR112022020003A2 (pt) | 2020-04-03 | 2021-04-02 | Matriz de tecido adiposo com tropoelastina |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210308336A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4126090A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023520788A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230005205A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115697428A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021247273A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022020003A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3179203A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022012377A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021202965A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10157182A1 (de) * | 2001-11-22 | 2003-06-05 | Matricel Gmbh | Verfahren zur Behandlung von Materialien biologischen Ursprungs und Elastin-Produkt |
| US20040197375A1 (en) * | 2003-04-02 | 2004-10-07 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
| AU2003902037A0 (en) * | 2003-04-24 | 2003-05-15 | Mclachlan, Craig | Method for tissue growth |
| US11395865B2 (en) * | 2004-02-09 | 2022-07-26 | DePuy Synthes Products, Inc. | Scaffolds with viable tissue |
| US20080269463A1 (en) * | 2005-03-04 | 2008-10-30 | Oregon Health & Science University | Tropoelastin Isoforms and Used Thereof |
| WO2008058323A1 (en) * | 2006-11-13 | 2008-05-22 | The University Of Sydney | Use of tropoelastin for repair or restoration of tissue |
| EP2520309A1 (en) * | 2007-07-27 | 2012-11-07 | Humacyte, Inc. | Compositions and methods for soft tissue augmentation |
| US9114128B2 (en) * | 2011-09-30 | 2015-08-25 | Protein Genomics, Inc. | Tropoelastins and uses thereof |
| WO2014063194A1 (en) * | 2012-10-23 | 2014-05-01 | The University Of Sydney | Elastic hydrogel |
| US10842913B2 (en) * | 2012-12-10 | 2020-11-24 | Allergan Pharmaceuticals International Limited | Scalable three-dimensional elastic construct manufacturing |
| AU2015353653A1 (en) * | 2014-11-26 | 2017-06-15 | Integra Lifesciences Corporation | Process for preparing tissue regeneration matrix |
| HK1257488A1 (zh) * | 2015-09-01 | 2019-10-25 | Allergan Pharmaceuticals International Limited | 骨形成 |
| CA3012849A1 (en) * | 2016-02-08 | 2017-08-17 | Lifecell Corporation | Biologic breast implant |
| US10959884B2 (en) * | 2016-04-08 | 2021-03-30 | Fiomet Ventures, Inc. | Pressure-sensing negative pressure therapy sponges and methods for the creation and use thereof |
| WO2017205740A1 (en) * | 2016-05-26 | 2017-11-30 | Integra Lifesciences Corporation | Process for preparing tissue regeneration matrix |
| US20200197566A1 (en) * | 2017-04-07 | 2020-06-25 | The Board Of Trustees Of The University Of Illinois | Directed plasma nanosynthesis (dpns) methods, uses and systems |
| CA3095736A1 (en) * | 2018-04-02 | 2019-10-10 | Bioaesthetics Corporation | Polymer-permeated grafts and methods of making and using the same |
| EP3976127B1 (en) * | 2019-05-30 | 2025-09-24 | LifeCell Corporation | Biologic breast implant |
-
2021
- 2021-04-02 US US17/221,207 patent/US20210308336A1/en not_active Abandoned
- 2021-04-02 BR BR112022020003A patent/BR112022020003A2/pt unknown
- 2021-04-02 KR KR1020227038610A patent/KR20230005205A/ko active Pending
- 2021-04-02 CN CN202180037202.1A patent/CN115697428A/zh active Pending
- 2021-04-02 WO PCT/US2021/025523 patent/WO2021202965A1/en not_active Ceased
- 2021-04-02 CA CA3179203A patent/CA3179203A1/en active Pending
- 2021-04-02 EP EP21720927.9A patent/EP4126090A1/en active Pending
- 2021-04-02 AU AU2021247273A patent/AU2021247273A1/en active Pending
- 2021-04-02 MX MX2022012377A patent/MX2022012377A/es unknown
- 2021-04-02 JP JP2022559962A patent/JP2023520788A/ja active Pending
-
2024
- 2024-04-11 US US18/632,995 patent/US20240416010A1/en active Pending
-
2025
- 2025-12-25 JP JP2025281297A patent/JP2026076164A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230005205A (ko) | 2023-01-09 |
| JP2026076164A (ja) | 2026-05-11 |
| US20210308336A1 (en) | 2021-10-07 |
| MX2022012377A (es) | 2023-02-09 |
| US20240416010A1 (en) | 2024-12-19 |
| JP2023520788A (ja) | 2023-05-19 |
| CA3179203A1 (en) | 2021-10-07 |
| EP4126090A1 (en) | 2023-02-08 |
| CN115697428A (zh) | 2023-02-03 |
| WO2021202965A1 (en) | 2021-10-07 |
| AU2021247273A1 (en) | 2022-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021024043A2 (pt) | Implante mamário biológico | |
| BR112013030492A2 (pt) | método para produzir um produto de tecido, produto de tecido produzido por um processo, método de tratamento, e sistema de tratamento | |
| BR112022013569A2 (pt) | Construções de célula viva para produção de produto lácteo cultivado e métodos usando as mesmas | |
| EP4541385A3 (en) | Adipose tissue products and methods of production | |
| PH12021551409A1 (en) | Kif18a inhibitors | |
| MX2021007104A (es) | Inhibidores de kif18a. | |
| MX2022001181A (es) | Inhibidores de kif18a. | |
| BR112021020616A2 (pt) | Novos métodos de tratamento de sementes e composições para o aprimoramento dos traços e rendimento de plantas | |
| ECSP20046463A (es) | Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas | |
| UY38701A (es) | Moléculas de unión a cd19, conjugados, composiciones que las comprenden y usos de las mismas | |
| BR112016002496A2 (pt) | composto de fórmula i, composição farmacêutica, método para inibição de kdm1a, método para tratamento de uma doença mediada por globina, método para atingir um efeito em um paciente, e, método para inibir pelo menos uma função de kdm1a | |
| BR112017014269A2 (pt) | células exterminadoras naturais e usos das mesmas | |
| BR112017027498A2 (pt) | anticorpo, ácido nucleico, composto, composição, e, método para tratamento de um paciente com uma doença. | |
| BR112013000822A2 (pt) | método e método de duas etapas para a produção de uma população de células exterminadoras naturais (nk) ativadas, população de células nk ativadas e método para suprimir a proliferação de células tumorais | |
| BR112013027307A2 (pt) | método para tratar uma matriz de tecido; matriz de tecido acelular | |
| EA201891507A1 (ru) | Кислая альфа-глюкозидаза усиленного действия для лечения болезни помпе | |
| BR112013003682A2 (pt) | métodos para tratar doenças neurodegenerativas | |
| PH12017501279B1 (en) | 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm) | |
| BR112013033841A2 (pt) | extrato de levedura dermatologicamente eficaz | |
| MX2021006398A (es) | Expansión de células asesinas naturales y células ilc3 con compuestos aromáticos novedosos. | |
| MX2021012335A (es) | Anticuerpos humanos que se unen a ret y metodos de uso de los mismos. | |
| MX2023012851A (es) | Métodos de tratamiento y seguimiento de la enfermedad de parkinson. | |
| MX2022002418A (es) | Composiciones y metodos de tratamiento de enfermedades vasculares. | |
| WO2020142740A8 (en) | Treatment of sjogren's disease with nuclease fusion proteins | |
| WO2020142750A3 (en) | Genetically modified cells, tissues, and organs for treating disease |